clarithromycin has been researched along with Staphylococcal Infections in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.56) | 18.7374 |
1990's | 12 (30.77) | 18.2507 |
2000's | 12 (30.77) | 29.6817 |
2010's | 10 (25.64) | 24.3611 |
2020's | 4 (10.26) | 2.80 |
Authors | Studies |
---|---|
Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Henry, RF; Kim, K; Nilius, AM; Or, YS; Pireh, D; Plattner, JJ; Raney, PM | 1 |
Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Kramer, MJ; Nilius, AM; Or, YS; Plattner, JJ; Raney, PM | 1 |
Agouridas, C; Auger, JM; Benedetti, Y; Bonnefoy, A; Bretin, F; Chantot, JF; D'Ambrières, SG; Denis, A; Dussarat, A; Fromentin, C; Lachaud, S; Laurin, P; Le Martret, O; Loyau, V; Tessot, N | 1 |
Asaka, T; Kameo, K; Kashimura, M; Misawa, Y; Morimoto, S; Nishida, A; Sato, M; Suzuki, K; Tanikawa, T | 1 |
Asaka, T; Kameo, K; Kashimura, M; Morimoto, S; Nishida, A; Sato, M; Sugiyama, H; Suzuki, K; Tanikawa, T | 1 |
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
Liu, Z; Ma, C; Ma, R; Ma, S; Shen, X | 1 |
Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
Liu, Y; Sun, FJ; Wang, Q; Xia, PY; Xie, LL; Xiong, LR | 1 |
An, K; Li, XL; Liang, JH; Wang, H; Wang, YY; Xu, YC; Yao, GW | 1 |
Kaneda, Y; Manaka, A; Nanaumi, K; Shimazaki, Y; Sugimoto, T; Sugiyama, H; Suzuki, K; Tanikawa, T; Yamasaki, Y | 1 |
Ma, P; Qin, Y; Sun, M; Yang, Y; Zhang, N | 1 |
Ahmad, Z; Arshad, MS; Patel, M; Rana, SJ; Yousef, B; Zafar, S | 1 |
Abed, N; Anversa Dimer, F; Bischoff, M; Cirnski, K; Couvreur, P; De Rossi, C; de Souza Carvalho-Wodarz, C; Goes, A; Herrmann, J; Lehr, CM; Müller, R; Pätzold, L; Schmitt, V | 1 |
Bagatti, D; Messina, G | 1 |
Huang, X; Li, C; Li, J; Li, Y; Su, T; Zhang, Y | 1 |
Koh, S; Maeda, N; Nishida, K | 1 |
DiCicco, M; Neethirajan, S; Singh, A; Weese, JS | 1 |
Fujii, T; Ito, A; Nakaminami, H; Noguchi, N; Utsumi, K | 1 |
de Souza Carvalho-Wodarz, C; Dimer, F; Hartmann, R; Haupenthal, J; Lehr, CM | 1 |
Carrillo-Alascio, PL; Guirao-Arrabal, E; León-Ruíz, L; Pérez-Sola, MJ | 1 |
Ariza, J; Cabellos, C; Cabo, J; El Haj, C; Garcia-Somoza, D; Murillo, O; Ribera, A; Tubau, F | 1 |
Li, X; Sun, N; Wang, J; Xiong, L | 1 |
Fujimura, S; Gomi, K; Kikuchi, T; Sato, T; Watanabe, A; Zaini, J | 1 |
Baba, S; Furuhata, M; Inoue, M; Iwamura, M | 1 |
Bartucci, F; Bohórquez, P; Ortega, C; Pellegrino, FA; Schlaen, A; Wainberg, P | 1 |
Andersson, DI; Blaser, MJ; Engstrand, L; Sjölund, M; Tano, E | 1 |
Abruzzo, GK; Bartizal, K; Flattery, AM; Gill, CJ; Jackson, J; Kong, L; Kropp, H; Shankaran, K; Smith, JG; Wilkening, R | 1 |
Müller, O | 1 |
Fietta, A; Gialdroni Grassi, G; Merlini, C | 1 |
Barg, N | 1 |
Calhoun, J; Mader, JT; Shirtliff, ME | 1 |
Cannon, BM; Conerly, LL; Dajcs, JJ; Hill, JM; Hume, EB; Moreau, JM; O'Callaghan, RJ | 1 |
Alter, P; Maisch, B; Schaefer, JR | 1 |
Ajiboye, P; Blokh, I; Braverman, AS; Burack, J; Gillette, P; Sobti, P; Solomon, W; Zinn, H | 1 |
Misawa, Y; Miyachi, J; Morimoto, S; Nagate, T; Numata, K; Omura, S; Ono, T; Sugita, K; Yamada, K | 1 |
Kohno, Y; Ohta, K; Suga, T; Suwa, T | 1 |
Cacciapuoti, AF; Cramer, CL; Hare, RS; Loebenberg, D; Mallams, AK; Menzel, FW; Miller, GH; Moss, EL; Naples, LR; Rudeen, JA | 1 |
Fernandes, PB; Hardy, DJ; McDonald, EJ; Ramer, N; Swanson, RN | 1 |
3 trial(s) available for clarithromycin and Staphylococcal Infections
Article | Year |
---|---|
[Oral clarithromycin as a treatment option in chronic post-operative endophthalmitis].
Topics: Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; Clarithromycin; Combined Modality Therapy; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Propionibacterium acnes; Prospective Studies; Prosthesis-Related Infections; Remission Induction; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Therapeutic Irrigation; Treatment Outcome; Vitrectomy | 2005 |
Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin.
Topics: Anti-Bacterial Agents; Case-Control Studies; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors | 2005 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Administration Schedule; Erythromycin; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1993 |
36 other study(ies) available for clarithromycin and Staphylococcal Infections
Article | Year |
---|---|
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Clarithromycin; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Mice; Molecular Conformation; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin | 1998 |
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Lincosamides; Macrolides; Mice; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin | 1998 |
Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Crystallography, X-Ray; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Ketolides; Macrolides; Male; Mice; Models, Molecular; Molecular Conformation; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus; Streptococcus pneumoniae | 1998 |
Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics.
Topics: Animals; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Structure-Activity Relationship | 2001 |
Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Drug Resistance, Multiple, Bacterial; Erythromycin; Haemophilus influenzae; Macrolides; Mice; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Streptococcal Infections; Streptococcus pneumoniae; Structure-Activity Relationship | 2003 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Synthesis and antibacterial activity of novel 15-membered macrolide derivatives: 4''-carbamate, 11,12-cyclic carbonate-4''-carbamate and 11,4''-di-O-arylcarbamoyl analogs of azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Carbamates; Carbonates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus pneumoniae | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Base Sequence; Biofilms; DNA Primers; Dose-Response Relationship, Drug; Erythromycin; Gene Expression; Genes, Bacterial; Humans; In Vitro Techniques; Macrolides; Microscopy, Electron, Scanning; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus epidermidis | 2010 |
Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2012 |
Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Halogenation; Humans; Ketolides; Microbial Sensitivity Tests; Models, Molecular; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus | 2012 |
Synthesis and biological evaluation of antibacterial activity of novel clarithromycin derivatives incorporating 1,2,3-triazole moieties at the 4''- and 11-OH positions.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Triazoles | 2022 |
Engineering of clarithromycin loaded stimulus responsive dissolving microneedle patches for the treatment of biofilms.
Topics: Administration, Cutaneous; Biofilms; Clarithromycin; Drug Delivery Systems; Humans; Hyaluronic Acid; Needles; Staphylococcal Infections; Staphylococcus aureus | 2023 |
PLGA nanocapsules improve the delivery of clarithromycin to kill intracellular Staphylococcus aureus and Mycobacterium abscessus.
Topics: Animals; Capsules; Clarithromycin; Drug Carriers; Mice; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; RAW 264.7 Cells; Staphylococcal Infections; Staphylococcus aureus; Zebrafish | 2020 |
Cytotoxic Lesion in the Splenium of Corpus Callosum Associated with Intracranial Infection After Deep Brain Stimulation.
Topics: Adult; Anti-Bacterial Agents; Brain Diseases; Clarithromycin; Corpus Callosum; Deep Brain Stimulation; Diffusion Magnetic Resonance Imaging; Humans; Implantable Neurostimulators; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Prosthesis Implantation; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Tomography, X-Ray Computed | 2020 |
Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection.
Topics: Animals; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Daptomycin; Disease Models, Animal; Liposomes; Methicillin-Resistant Staphylococcus aureus; Mice; Polyethylene Glycols; Staphylococcal Infections; Treatment Outcome | 2015 |
Visualization of the meibomian glands by means of noncontact mobile-type meibography (Meibopen) in a 16-year-old girl with unilateral marginal staphylococcal keratitis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Anti-Bacterial Agents; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Eyelid Diseases; Female; Fluorometholone; Humans; Levofloxacin; Meibomian Glands; Staphylococcal Infections; Visual Acuity | 2014 |
In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Clarithromycin; Dogs; Drug Synergism; Fosfomycin; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Staphylococcal Infections; Staphylococcus | 2014 |
Increase in SCCmec type IV strains affects trends in antibiograms of meticillin-resistant Staphylococcus aureus at a tertiary-care hospital.
Topics: Bacterial Toxins; Bacterial Typing Techniques; Cefotaxime; Chromosomes, Bacterial; Clarithromycin; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterotoxins; Exotoxins; Humans; Interspersed Repetitive Sequences; Japan; Leukocidins; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcal Infections; Superantigens; Tertiary Care Centers; Virulence Factors | 2015 |
Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Cell Line; Clarithromycin; Dry Powder Inhalers; Escherichia coli; Escherichia coli Infections; Humans; Particle Size; Respiratory Tract Infections; Solubility; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Defibrillators, Implantable; Echocardiography; Humans; Linezolid; Male; Myocardial Ischemia; Prosthesis-Related Infections; Staphylococcal Infections; Treatment Outcome | 2016 |
The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
Topics: Animals; Anti-Bacterial Agents; Biofilms; Clarithromycin; Daptomycin; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Foreign Bodies; Microbial Sensitivity Tests; Microbial Viability; Rats; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2017 |
[Different concentrations of clarithromycin ophthalmic gel for rabbits corneal ulcers induced by Staphylococcus aureus].
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Clarithromycin; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Gels; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Efficacy of clarithromycin plus vancomycin in mice with implant-related infection caused by biofilm-forming Staphylococcus aureus.
Topics: Animals; Biofilms; Clarithromycin; Drug Therapy, Combination; Female; Infusions, Intravenous; Mice; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Titanium; Vancomycin | 2009 |
Combined effect of clarithromycin and imipenem/cilastatin against urinary biofilm infection after pyeloplasty.
Topics: Adult; Biofilms; Cilastatin; Clarithromycin; Drug Therapy, Combination; Humans; Imipenem; Kidney Calculi; Kidney Pelvis; Male; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Ureteral Obstruction | 2003 |
In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Drug Evaluation, Preclinical; Drug Stability; Erythromycin; Female; Half-Life; Klebsiella Infections; Macrolides; Mice; Mice, Inbred DBA; Molecular Structure; Staphylococcal Infections; Streptococcal Infections | 1995 |
Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin.
Topics: Azithromycin; Cell-Free System; Clarithromycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Monocytes; Neutrophils; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Clarithromycin; Disease Models, Animal; Erythromycin; Fasciitis, Necrotizing; Mice; Mice, Hairless; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes | 1998 |
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azithromycin; Biological Availability; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Nafcillin; Osteomyelitis; Rabbits; Rifampin; Staphylococcal Infections; Tibia; Treatment Outcome | 1999 |
Clarithromycin for experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Erythromycin; Keratitis; Minocycline; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 1999 |
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis].
Topics: Agranulocytosis; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Clarithromycin; Coronary Disease; Drug Therapy, Combination; Echocardiography, Doppler; Endocarditis, Bacterial; Fibrinolytic Agents; Gentamicins; Humans; Imipenem; Immunity, Cellular; Leukocyte Count; Leukocytes; Leukopenia; Male; Middle Aged; Platelet Aggregation Inhibitors; Staphylococcal Infections; Thienamycins; Ticlopidine; Time Factors; Vancomycin | 2000 |
A rare case of osteomyelitis of the sternum in an adult with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Chest Pain; Clarithromycin; Dicloxacillin; Femur Head Necrosis; Fever; Humans; Ilium; Infarction; Male; Osteomyelitis; Pelvic Pain; Penicillins; Sacrum; Staphylococcal Infections; Sternum | 2001 |
Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032.
Topics: Animals; Bacteria; Clarithromycin; Dogs; Erythromycin; Hydrogen-Ion Concentration; Josamycin; Male; Mice; Mice, Inbred ICR; Rabbits; Rats; Rats, Inbred Strains; Staphylococcal Infections; Streptococcal Infections | 1990 |
Autobacteriographic studies of clarithromycin and erythromycin in mice.
Topics: Administration, Oral; Animals; Autoradiography; Carbon Radioisotopes; Clarithromycin; Erythromycin; Male; Mice; Mice, Inbred ICR; Staphylococcal Infections; Tissue Distribution | 1990 |
Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivatives.
Topics: Animals; Clarithromycin; Erythromycin; Male; Mice; Molecular Structure; Saimiri; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Tylosin | 1990 |
Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Erythromycin; Injections, Subcutaneous; Mice; Staphylococcal Infections; Streptococcal Infections | 1988 |